Hematology - European Medical Journal

Continue

Hematology

Articles
17 Mins
14th September 2023

Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition

This continuing medical education-accredited symposium, held at the 2023 International Society for Thrombosis and Haemostasis (ISTH)…
12 Mins
1st August 2023

Expert Insights: Phase III Clinical Trials in Non-Transfusion-Dependent (ENERGIZE) and Transfusion-Dependent (ENERGIZE-T) α- and β-Thalassaemia

The thalassaemias are a heterogeneous group of inherited chronic blood disorders associated with impaired haemoglobin (Hb) synthesis…
14 Mins
1st August 2023

What to Do When Chimeric Antigen Receptor T Cells Are Not the Most Appropriate Option in Second-Line Diffuse Large B Cell Lymphoma: Current Treatment Options for Transplant-Ineligible Patients

DLBCL accounts for approximately 30% of non-Hodgkin’s lymphomas diagnosed each year. Initially, DLBCL is generally treated…
13 Mins
20th July 2023

Untangling Systemic Mastocytosis: An Update on Challenges in the Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis

The overarching message from the symposium was that diagnosis of SM-AHN is challenging, and SM is often missed in patients with a myeloid…
13 Mins
20th July 2023

Steroid Toxicity in Immune Thrombocytopenia

This article summarises the occurrence of very unusual and rare steroid-related toxicity. It is a cautionary tale of modern medicine where the treatment-related adverse events are more atrocious than the primary disease.
8 Mins
30th May 2023

Interview: Janis Abkowitz

Janis Abkowitz | Head, Division of Hematology, University of Washington, Seattle, USA; Adjunct Professor of Genome Sciences, University of…
10 Mins
19th May 2023

Interview: Cynthia Dunbar

Cynthia Dunbar – Secretary, American Society of Hematology (ASH); Chief, Translational Stem Cell Biology Branch, and Head, Molecular…
18 Mins
15th February 2023

Realising the Promise of Gene Therapy for Haemophilia: Current Status and Future Innovations

Gene therapy for haemophilia A and B was discussed during several sessions at the 64th American Society of Hematology (ASH) Annual Meeting, held 10th–13th December 2022.